Can repeated innate immune activation drive chronic pain and fatigue through neuroinflammation?

The interaction between the innate immune system and the central nervous system (CNS) is a primary driver in the development of chronic pain and fatigue syndromes. Repeated activation of the innate immune response initiates a cascade that shifts the CNS from a homeostatic state to one of sustained neuroinflammation and hypersensitivity.

Mechanistic pathways of immune activation

Repeated innate immune activation triggers resident glial cells—primarily microglia and astrocytes—via pattern recognition receptors (PRRs) like TLR4. This engagement activates intracellular signaling pathways, such as NF-κB and the cGAS-STING pathway, leading to the chronic release of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α. This process is often self-perpetuating; initial cytokine release increases blood-brain barrier permeability, allowing peripheral inflammatory monocytes (CCR2+) to infiltrate the CNS. These cells differentiate into macrophages, amplifying the cytokine environment and creating feedback loops that bypass normal regulatory mechanisms.

From neuroinflammation to central sensitization

Elevated CNS cytokines directly alter neuronal function, facilitating central sensitization. Specifically, IL-1β and TNF-α promote the phosphorylation and trafficking of NMDA receptors (NMDAR) in the spinal cord dorsal horn, enhancing glutamatergic signaling and neuronal hyperexcitability. This neuro-immune crosstalk shifts the balance between excitatory and inhibitory (GABAergic) neurotransmission and promotes long-term potentiation (LTP) in pain pathways. These transcriptional and synaptic changes maintain a state of "nociplastic" pain where the nervous system remains in a high-alert state even without ongoing tissue damage.

Clinical implications for pain and fatigue

Central sensitization is a foundational mechanism for conditions like fibromyalgia and chronic fatigue syndrome (ME/CFS). Research indicates that sensitization is not only a source of widespread pain but also an independent predictor of fatigue severity. Longitudinal data suggests that heightened central sensitivity (measured via pressure pain thresholds) prospectively predicts fatigue levels, likely due to shared neuroplastic pathways.

Bottom line

Repeated innate immune activation drives chronic pain and fatigue by sustaining a pro-inflammatory CNS environment. This neuroinflammation triggers central sensitization through glial-neuronal interactions and glutamatergic hyperexcitability, fundamentally altering how the brain processes sensory information.